microvascular
blood ﬂow,
transcutaneous
oxygen pressure,
leg edema
Improvement of
microvascular
blood ﬂow, oxygen
pressure and leg
circumference (P <
.0001)

Rabe E,
2011306

Adults with
varicose
veins and
CEAP C3-C4a
n ¼ 248

Red vine leaf
extract

Placebo

Leg volume by water RCT
plethysmography
Symptoms (10-cm
VAS). Global
efﬁcacy
evaluations.
Signiﬁcantly reduced
limb volume (P ¼
.0268) and
improved pain (P ¼
.047)

Systematic
review. 5
trials

Crossover
RCT vs
placebo

Age, sex, different stages of
CVD in patients with
varicose veins

Age, sex, different stages of
CVD in patients with
varicose veins

Age, sex, different stages of
CVD in patients with
varicose veins

Age, sex, different stages of
CVD in patients with
varicose veins

CEAP, Clinical stage, etiology, anatomy, pathology; CVD, chronic venous disease; CVI, chronic venous insufﬁciency; RCT, randomized controlled trial;
VAD, venoactive drugs; randomized controlled trial; VAS, visual analog scale.

Gloviczki et al

Journal of Vascular Surgery: Venous and Lymphatic Disorders

43

Volume 12, Number 1

Table XXX. Clinical beneﬁt of sulodexide

First
author,
year

Patient

Intervention/exposure

Comparison

Outcomes

Study design

Possible explanations of heterogeneity (factors to be
used to stratify
analysis)

None or Leg edema reduction
heparan
assessed by volumetry, and
sulphate
venous symptoms
(heaviness, tingling and
pain).
Decrease of pain, cramps,
heaviness, edema and total
symptoms score. Reduced
inﬂammatory mediators.
Low risk of adverse events
(3%)

Systematic review
and meta-analysis
of 1